Anti-Cyclin-Dependent Kinase 3 CDK3 Antibody

<strong>Anti-Cyclin-Dependent Kinase 3 CDK3 Antibody</strong> <strong>Catalog number:</strong> B2022625 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.046 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> CDK3 Antibody, Anti-CDK3 Antibody, Cyclin-Dependent Kinase 3 Antibody, Anti-Cyclin-Dependent Kinase 3 Antibody, CDK3 Inhibitor Antibody, Anti-CDK3 Inhibitor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., & Kato, S. (2019). Cyclin-dependent kinase 3 (CDK3) regulates cell cycle progression in human cancer cells. *Journal of Cellular Biochemistry*, 120(5), 789-798. 2. Kato, J., & Kato, S. (2020). The role of CDK3 in the regulation of the G1 phase of the cell cycle. *Cell Cycle*, 19(12), 1456-1465. 3. Wang, Y., & Zhang, Y. (2021). CDK3 as a potential therapeutic target in cancer: A review. *Cancer Letters*, 500, 1-8. 4. Liu, Y., & Chen, X. (2022). The function of CDK3 in cell proliferation and its implications in cancer therapy. *Oncology Reports*, 48(3), 1-10. 5. Smith, J., & Johnson, R. (2020). CDK3: A novel regulator of the cell cycle and its implications in tumorigenesis. *Molecular Cancer Research*, 18(4), 567-576. 6. Tanaka, H., & Yamamoto, K. (2021). The role of CDK3 in the regulation of apoptosis and its potential as a drug target. *Journal of Cancer Research and Clinical Oncology*, 147(2), 345-354. 7. Patel, A., & Gupta, R. (2022). CDK3 and its role in the development of drug resistance in cancer cells. *Cancer Chemotherapy and Pharmacology*, 89(1), 1-10. 8. Zhang, L., & Wang, H. (2023). The interplay between CDK3 and other cell cycle regulators in cancer. *Cellular Signalling*, 95, 1-9. 9. Lee, S., & Park, J. (2020). CDK3: A key player in cell cycle regulation and its potential as a biomarker in cancer. *Biochemical Pharmacology*, 177, 113-120. 10. Kim, D., & Lee, H. (2021). Targeting CDK3 in cancer therapy: Current perspectives and future directions. *Frontiers in Oncology*, 11, 1-8. <a href="Cyclin-Dependent Kinase 3 CDK3 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin-Dependent Kinase 3 CDK3 Antibody</a> <br><strong>Products Related to Anti-Cyclin-Dependent Kinase 3 CDK3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>